Minocycline inhibits in vitro invasion and experimental pulmonary metastasis of mouse renal adenocarcinoma

Adv Dent Res. 1998 Nov;12(2):111-3. doi: 10.1177/08959374980120010201.
No abstract available

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Carcinoma, Renal Cell / drug therapy*
  • Carcinoma, Renal Cell / enzymology
  • Carcinoma, Renal Cell / secondary*
  • Endothelial Growth Factors / antagonists & inhibitors
  • Fibroblast Growth Factor 2 / antagonists & inhibitors
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / enzymology
  • Kidney Neoplasms / pathology*
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / enzymology
  • Lung Neoplasms / secondary*
  • Lymphokines / antagonists & inhibitors
  • Matrix Metalloproteinase Inhibitors
  • Metalloendopeptidases / antagonists & inhibitors
  • Mice
  • Minocycline / pharmacology*
  • Minocycline / therapeutic use
  • Neoplasm Invasiveness
  • Neoplasm Metastasis
  • Protease Inhibitors / pharmacology
  • Protease Inhibitors / therapeutic use
  • Statistics, Nonparametric
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Anti-Bacterial Agents
  • Endothelial Growth Factors
  • Lymphokines
  • Matrix Metalloproteinase Inhibitors
  • Protease Inhibitors
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Fibroblast Growth Factor 2
  • Metalloendopeptidases
  • Minocycline